The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-{2-[4-(5-methoxy-1H-indol-3-yl)piperidin-1-yl]ethyl}-3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione ID: ALA4572132
PubChem CID: 155563205
Max Phase: Preclinical
Molecular Formula: C28H29FN4O3
Molecular Weight: 488.56
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2[nH]cc(C3CCN(CCN4C(=O)CC(c5c[nH]c6ccc(F)cc56)C4=O)CC3)c2c1
Standard InChI: InChI=1S/C28H29FN4O3/c1-36-19-3-5-26-21(13-19)23(15-30-26)17-6-8-32(9-7-17)10-11-33-27(34)14-22(28(33)35)24-16-31-25-4-2-18(29)12-20(24)25/h2-5,12-13,15-17,22,30-31H,6-11,14H2,1H3
Standard InChI Key: LAJRCGYWMBTWLT-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
22.6176 -21.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4032 -21.7449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8760 -21.0755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3801 -20.4187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6033 -20.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6231 -19.6331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6972 -21.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1223 -21.7617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9392 -21.7439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3607 -22.4470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1742 -22.4312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5711 -21.7165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1484 -21.0160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3287 -21.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3837 -21.7001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8759 -22.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6484 -22.0859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.6295 -21.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8521 -21.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6682 -20.2429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2580 -19.6877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0395 -19.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2226 -20.7153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6734 -22.5217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9642 -22.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9784 -22.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2017 -23.0890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7057 -22.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1805 -21.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8350 -21.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0192 -20.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5500 -21.6207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8939 -22.3605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6756 -20.2046 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.0707 -18.8923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6659 -18.3324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
4 6 2 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
9 14 1 0
12 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
19 18 2 0
19 15 1 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
2 24 2 0
1 25 1 0
26 25 2 0
27 26 1 0
28 27 1 0
28 29 2 0
25 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
31 34 1 0
21 35 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.56Molecular Weight (Monoisotopic): 488.2224AlogP: 4.52#Rotatable Bonds: 6Polar Surface Area: 81.43Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.49CX LogP: 3.38CX LogD: 2.26Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: -0.81
References 1. Wróbel MZ, Chodkowski A, Herold F, Marciniak M, Dawidowski M, Siwek A, Starowicz G, Stachowicz K, Szewczyk B, Nowak G, Belka M, Bączek T, Satała G, Bojarski AJ, Turło J.. (2019) Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect., 183 [PMID:31586817 ] [10.1016/j.ejmech.2019.111736 ]